Cash Flow Mega Genomics Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
No of Months
12
12
12
12
12
12
Profit Before Tax
39.00
-24.00
115.00
106.00
43.00
14.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
139.00
-7.00
-94.00
-9.00
-45.00
-66.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
179.00
-8.00
35.00
113.00
36.00
-15.00
Cash Flow from Investing Activities
-37.00
-2.00
-2.00
-34.00
20.00
-27.00
Cash Flow from Financing Activities
-13.00
185.00
4.00
96.00
-19.00
20.00
Net Cash Inflow / Outflow
130.00
186.00
36.00
0.00
-2.00
2.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
13.00
-1.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mega Genomics Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
39.9777225417536
-276.792588976788
315.00
114.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
139.67395684576
37.1758671117905
102.00
275.71%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
179.630684425566
249.284745868609
-70.00
-27.94%
Cash Flow from Investing Activities
-37.2981023984729
-57.7468460756264
20.00
35.41%
Cash Flow from Financing Activities
-13.0268213893345
-311.035630594604
298.00
95.81%
Net Cash Inflow / Outflow
130.895852755771
-119.508573040046
249.00
209.53%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.59009211801275
-0.0108422384250439
1.00
14765.72%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'23
YoY Growth in year ended Dec 2023 is 2,124.52% vs -124.67% in Dec 2022
Dec'23
Dec'22
Change(%)
Cash Flow from Operating Activities
179.63
-8.87
2,124.52%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
